{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:15:28Z","timestamp":1788178528135,"version":"build-2803163510"},"reference-count":30,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>Background: Evidence from experimental and clinical studies suggests that anesthetic drugs may modulate tumor biology by influencing immune regulation, inflammation and intracellular calcium signaling. However, the extent to which sevoflurane or propofol alters calcium-related molecular expression in human breast cancer tissue remains unclear. Objectives: This study aimed to compare the effects of sevoflurane- versus propofol-based anesthesia on calcium signaling pathway\u2013related gene and protein expression in breast cancer tissues and to evaluate their association with early -postoperative recovery and short-term oncologic outcomes. Methods: A total of 38 female patients undergoing breast cancer surgery were prospectively randomized to the sevoflurane group (S group, n=19) or the propofol group (P group, n=19). Paired tumor and adjacent normal tissues were collected intra-operatively. mRNA expression of RYR2 and CALML5 was quantified using RT-qPCR and protein levels were assessed by Western blotting. Postoperative pain was evaluated using the 24-hour resting numerical rating scale (NRS), recovery quality using the quality of recovery-15 (QoR-15) on post-operative day 1 and incision pain at post-operative months 3 and 6. Tumor recurrence or metastasis was monitored for 6 months. Results: Compared with the propofol group, sevoflurane anesthesia demonstrated a nonsignificant upward trend in RYR2 mRNA and protein expression (P&gt;0.05), whereas CALML5 expression showed a significant increase under sevoflurane (P&lt;0.001). No significant intergroup differences were detected in 24-hour NRS scores, post-operative QoR-15, chronic incision pain at 3 or 6 months, or 6-month recurrence\/metastasis rates (all P&gt;0.05). Conclusion: Sevoflurane anesthesia induced a selective increase in CALML5 expression compared with propofol, suggesting potential differential modulation of calcium-associated molecular pathways. However, these molecular changes did not translate into measurable differences in early recovery, post-operative pain, or short-term oncologic prognosis. The findings support the clinical non-inferiority of sevoflurane compared with propofol and provide preliminary molecular evidence to guide future mechanism-based perioperative investigations.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.8.239.1","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:11:25Z","timestamp":1781010685000},"source":"Crossref","is-referenced-by-count":0,"title":["Differential Effects Of Sevoflurane Versus Propofol On Calmodulin Expression In Breast Cancer Patients"],"prefix":"10.36721","author":[{"given":"Jiahui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Alam A, Rampes S, Patel S, Hana Z and Ma D (2021). Anesthetics or anesthetic techniques and cancer surgical outcomes: A possible link. Korean J. Anesthesiol., 74(3): 191-203.","DOI":"10.4097\/kja.20679"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Breivik Hals EK, Kvarstein G and Stubhaug A (2008). Assessment of pain. Br. J. Anaesth., 101(1): 17-24.","DOI":"10.1093\/bja\/aen103"},{"key":"ref2","unstructured":"Bu XS, Li XY, Wang Q, Xu M, Zhang XZ, Wang X, Liu K, Zhang Q and Wu AL (2016). Validation of the Chinese version of the quality of recovery-15 score and its comparison with the post-operative quality recovery scale. Patient Relat. Outcome Meas., 7: 121-127"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Chang Q, Wu J, An Y, Liu H and Sun Y (2022). Propofol suppresses proliferation, migration, invasion and tumor growth of liver cancer cells via CSC9\/PTEN\/AKT\/mTOR axis. Hum. Exp. Toxicol., 41: 9603271211065972.","DOI":"10.1177\/09603271211065972"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Cui C, Merritt R, Fu L and Pan Z (2017). Targeting calcium signaling in cancer therapy. Acta Pharm. Sin. B, 7(1): 3-17.","DOI":"10.1016\/j.apsb.2016.11.001"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Deng X, Vipani M and Liang G (2020). Sevoflurane modulates breast cancer cell survival via intracellular calcium homeostasis. BMC Anesthesiol., 20(1): 253.","DOI":"10.1186\/s12871-020-01139-y"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Fang P, Zhou J, Xia Z, Luo Y and Liu X (2022). Effects of propofol versus sevoflurane on breast cancer prognosis: Narrative review. Front. Oncol., 11: 793093.","DOI":"10.3389\/fonc.2021.793093"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hu W, Luo J, Li H, Xu J, Zhang Y and Cheng Y (2025). Identification of key genes in esketamine's therapeutic effects on perioperative neurocognitive disorders based on RNA sequencing. Drug Des. Devel. Ther., 19: 981-1000.","DOI":"10.2147\/DDDT.S510752"},{"key":"ref8","unstructured":"Iqbalbhai SA, Dholakia RH and Patel SA (2025). Impact of anaesthesia on cancer recurrence: A systematic review. J. Contemp. Clin. Pract., 11(4): 243-250."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Jiang M, Wang Y, Zhao X and Yu J (2024). From metabolic by-product to immune modulator: The role of lactate in tumor immune escape. Front. Immunol., 15: 1492050.","DOI":"10.3389\/fimmu.2024.1492050"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lan Q, Ouyang A, Chen Y, Li Y, Zhong B and Deng S (2025). Pain, lactate and anesthetics: Intertwined regulators of tumor metabolism and immunity. Front. Oncol., 15: 1534300.","DOI":"10.3389\/fonc.2025.1534300"},{"key":"ref11","unstructured":"Ling YZ, Zhang XW, Wang X, Zhang CF, Li Y and Guo HY (2021). Changes of CaM-CaMK-CREB signaling after sevoflurane and propofol administration in rats. Eur. Rev. Med. Pharmacol. Sci., 25(2): 957-967."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Liu Q, Sheng Z, Cheng C, Zheng H, Lanuti M, Liu R, Wang P, Shen Y and Xie Z (2021). Propofol promotes lung tumor metastasis via GABAA-R-TRIM21-Src axis. Adv. Sci. (Weinh)., 8(18): e2102079.","DOI":"10.1002\/advs.202102079"},{"key":"ref13","unstructured":"Lukoseviciene V, Tikuisis R, Dulskas A, Miliauskas P and Ostapenko V (2018). Surgery for TNBC: Does anesthesia influence oxidative stress, inflammation, molecular regulators and outcomes? J. BUON, 23(2): 290-295."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Martin Ventura S, Garcia Molina C, Ortigosa Solorzano E, Garcia Vela JA, Thuissard Vasallo IJ, Lorente Ruifernandez MT, Gallego Gil P, Martin Rubio I and Esteban A (2022). Immune response in breast cancer surgery: A comparative and prospective study of different anesthetic techniques. Rev. Esp. Anestesiol. Reanim. (Engl. Ed.)., 69(6): 336-344.","DOI":"10.1016\/j.redare.2021.06.002"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Montazeri Aliabadi H (2024). Molecular targets for breast cancer therapy. Biomolecules, 14(10): 1219.","DOI":"10.3390\/biom14101219"},{"key":"ref16","unstructured":"Oh CS, Hong SW, Park S, Kim HJ, Kim SH, Lee SH, Lim C, Kim KS and Lee EH (2022). Equipotent propofol vs sevoflurane on ER stress during breast cancer surgery. Korean J. Anesthesiol., 75(6): 487-495."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Osman V, Speigel I, Patel K and Hemmings HC Jr (2023). Isoflurane alters presynaptic endoplasmic reticulum calcium dynamics. eNeuro, 10(8): ENEURO.0114-23.2023.","DOI":"10.1523\/ENEURO.0114-23.2023"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Shapovalov G, Gordienko D and Prevarskaya N (2021). Store-operated calcium channels in cancer progression. Int. Rev. Cell Mol. Biol., 363: 123-168.","DOI":"10.1016\/bs.ircmb.2021.02.016"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Stark PA, Myles PS and Burke JA (2013). Development and evaluation of the QoR-15. Anesthesiology, 118(6): 1332-1340.","DOI":"10.1097\/ALN.0b013e318289b84b"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Sun C, Liu P, Pei L, Zhao S and Huang Y (2022). Propofol inhibits proliferation and augments the antitumor effect of doxorubicin and paclitaxel partly through promoting ferroptosis in triple-negative breast cancer cells. Front. Oncol., 12: 837974.","DOI":"10.3389\/fonc.2022.837974"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Sun D, Li K, Chai Z, Wang Y, Wang Y and Zhang X (2024). Effects of propofol and inhalation anesthesia on T-cell activity after breast cancer surgery: Meta-analysis. J. Res. Med. Sci., 28: 86.","DOI":"10.4103\/jrms.jrms_336_23"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Sun P, Huang H, Ma J, Feng B, Zhang Y, Qin G, Zeng W and Cui Z (2024). Repurposing propofol for breast cancer therapy through promoting apoptosis and arresting cell cycle. Oncol. Rep., 52(5): 155.","DOI":"10.3892\/or.2024.8814"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Taniwaki M, Kitazawa R, Haraguchi R, Ono T, Takaoka Y and Kitazawa S (2025). CALML5 expression in SCC of esophagus and oropharynx. Acta Histochem. Cytochem., 58(2): 45-57.","DOI":"10.1267\/ahc.24-00064"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Wang S, Li M, Cai S and Zhang W (2023). Differential inflammatory effects between propofol and sevoflurane during lung cancer resection: A randomized pilot. World J. Surg. Oncol., 21(1): 8.","DOI":"10.1186\/s12957-023-02891-4"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Xu Y, Jiang W, Xie S, Xue F and Zhu X (2020). Role of inhaled anesthetics in tumorigenesis and tumor immunity. Cancer Manag. Res., 12: 1601-1609.","DOI":"10.2147\/CMAR.S244280"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Xu Y, Pan S, Jiang W, Xue F and Zhu X (2020). Effects of propofol on the development of cancer in humans. Cell Prolif., 53(8): e12867.","DOI":"10.1111\/cpr.12867"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Xu Z, Xiang L, Wang R, Peng X, Jiang Y, Zhu H and Xing T (2021). Immune significance of RYR2 mutation in breast cancer: A bioinformatic study. Biomed. Res. Int., 2021: 8072796.","DOI":"10.1155\/2021\/8072796"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yan R, Song T, Wang W, Tian J and Ma X (2023). Immunomodulatory roles of propofol and sevoflurane in murine models of breast cancer. Immunopharmacol. Immunotoxicol., 45(2): 153-159.","DOI":"10.1080\/08923973.2022.2122501"},{"key":"ref29","unstructured":"Zhou X, Shao Y, Li S, Chen L, Wang H, Ma X and Yu S (2022). Propofol influences malignant tumor biology and reshapes the tumor microenvironment: A narrative"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:26:36Z","timestamp":1788175596000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.8.239.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]}}}